Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Medical Specialties (16)
- Community Health and Preventive Medicine (14)
- Health Services Research (14)
- Health Services Administration (10)
- Medical Education (9)
-
- Family Medicine (8)
- Social and Behavioral Sciences (8)
- Medical Humanities (7)
- Physical Sciences and Mathematics (7)
- Environmental Public Health (6)
- Epidemiology (6)
- Public Health Education and Promotion (6)
- Statistics and Probability (6)
- Mental and Social Health (5)
- Primary Care (5)
- Substance Abuse and Addiction (5)
- Biostatistics (4)
- Diseases (4)
- Life Sciences (4)
- Women's Health (4)
- Behavior and Behavior Mechanisms (3)
- Cardiology (3)
- Endocrinology, Diabetes, and Metabolism (3)
- Environmental Microbiology and Microbial Ecology (3)
- Health and Medical Administration (3)
- International Public Health (3)
- Law (3)
- Microbiology (3)
- Keyword
-
- Residency (4)
- Communication (3)
- Family medicine (3)
- Medical education (3)
- Quality improvement (3)
-
- United States (3)
- 340B (2)
- Colorectal cancer (2)
- Community health (2)
- Data analysis (2)
- Disparities (2)
- Drug discount program (2)
- Effectiveness (2)
- Health reform (2)
- Health systems (2)
- Hospital (2)
- Human rights (2)
- Longitudinal curriculum (2)
- Low-income populations (2)
- Microbial enzyme (2)
- Needle exchange (2)
- Obesity (2)
- Patient care (2)
- Patient satisfaction (2)
- Pharmacist (2)
- Population health (2)
- Prescriber (2)
- Prescription drug abuse (2)
- Primary care (2)
- Qualitative (2)
- Publication
-
- Dennis J. Baumgardner, MD (6)
- Arsham Alamian (5)
- Judith A. Savageau (4)
- Nicholas E. Hagemeier (4)
- Alberto Coustasse, DrPH, MD, MBA, MPH (3)
-
- Andrew Lover (3)
- Phillip R. Scheuerman (3)
- Angela M. Hagaman (2)
- Billy Brooks (2)
- Jeffrey Stearns, MD (2)
- Julie Merten (2)
- Lisa Lieberman (2)
- Will Lehmann, MD (2)
- Aydin Nazmi (1)
- Benjamin U. Nwosu (1)
- Carrie Dolan (1)
- Colleen Nichols (1)
- Daina Dickman, MA, MLIS, AHIP (1)
- Deborah Simpson, PhD (1)
- Dr Katherine Dix (1)
- Enid F. Trucios-Haynes (1)
- Fabiana Kotovicz, MD (1)
- Jacob Bidwell, MD (1)
- Jarrett D. Gerlach (1)
- John B. Bossaer (1)
- Jon Miller (1)
- Karthikeyan Umapathy (1)
- Katharine Van Tassel (1)
- Margie J. Phillips (1)
- Marilyn Mitchell (1)
Articles 61 - 62 of 62
Full-Text Articles in Public Health
Prevalence And Risk Factors For Asymptomatic Malaria And Genotyping Of Glucose 6-Phosphate (G6pd) Deficiencies In A Vivax-Predominant Setting, Lao Pdr: Implications For Sub-National Elimination Goals, Andrew A. Lover, Emily Dantzer, Bouasy Hongvanthong, Keobouphaphone Chindavongsa, Susie Welty, Tania Reza, Nimol Khim, Didier Menard, Adam Bennett
Prevalence And Risk Factors For Asymptomatic Malaria And Genotyping Of Glucose 6-Phosphate (G6pd) Deficiencies In A Vivax-Predominant Setting, Lao Pdr: Implications For Sub-National Elimination Goals, Andrew A. Lover, Emily Dantzer, Bouasy Hongvanthong, Keobouphaphone Chindavongsa, Susie Welty, Tania Reza, Nimol Khim, Didier Menard, Adam Bennett
Andrew Lover
Background
Lao People Democratic Republic (PDR; Laos), a landlocked country in Southeast Asia, has made important progress in reducing malaria morbidity and mortality in the past 5–6 years, and the northern provinces have very low reported incidence. To support national progress towards elimination, it is critical to verify and understand these changes in disease burden.
Methods
A two-stage cluster cross-sectional survey was conducted in four districts within four northern provinces (Khua, Phongsaly Province; Paktha, Bokeo Province; Nambak, Luang Prabang, and Muang Et, Huaphanh Province). During September and October 2016, demographics and malaria risk factors were collected from a total of 1492 …
Malaria Elimination: Time To Target All Species, Andrew A. Lover, J. Kevin Baird, Roly Gosling, Ric N. Price
Malaria Elimination: Time To Target All Species, Andrew A. Lover, J. Kevin Baird, Roly Gosling, Ric N. Price
Andrew Lover
Important strides have been made within the past decade toward malaria elimination in many regions, and with this progress, the feasibility of eradication is once again under discussion. If the ambitious goal of eradication is to be achieved by 2040, all species of Plasmodium infecting humans will need to be targeted with evidence-based and concerted interventions. In this perspective, the potential barriers to achieving global malaria elimination are discussed with respect to the related diversities in host, parasite, and vector populations. We argue that control strategies need to be reorientated from a sequential attack on each species, dominated by Plasmodium …